Updated Rapid Risk Assessment: Severe respiratory disease associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
As of 17 June 2013, 64 cases of MERS-CoV had been reported worldwide, including 38 deaths. All cases remain associated (including indirect association following secondary person-to-person transmission in the UK, Italy, Tunisia and France) with transmission in the Middle East. The age of cases ranges from two years to 94 years (N=60 cases, information on age not available for four cases), with a median of 56 years. Overall 70% (43/61) of cases are males.
The reports of new infections in Saudi Arabia over the past few weeks indicate that there is an ongoing source of infection and low risk of transmission to humans in the Middle East.
Risk assessment: Wild-type poliovirus 1 transmission in Israel – what is the risk to Europe?
The EU/EEA countries and the rest of the WHO European Region, have been officially polio-free since 2002. However, wild-type polio virus 1 (WPV1) has been isolated in sewage and in the faeces of asymptomatic carriers in Israel since February 2013. In this risk assessment ECDC looks at the potential impact of this public health event on the risk of poliovirus being imported and re-established into circulation in EU/EEA.
Risk of introduction and transmission of wild-type poliovirus in EU/EEA countries following events in Israel and Syria – updated risk assessment (9 December 2013)
The confirmed circulation of wild-type poliovirus (WPV) in Israel and the outbreak of poliomyelitis in Syria mean that there is a high risk the disease will be reintroduced into the EU/EEA.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). Eleventh update, 21 August 2014
This eleventh updated rapid risk assessment on MERS-CoV shows that the number of cases has been steadily declining in the last few months.
Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 12th update, 16 October 2014
The risk to the EU posed by the outbreak of MERS-CoV remains low. The latest importation to the EU is not unexpected and does not indicate a significant change in the epidemiology of the disease.
Rapid Risk Assessment: Outbreaks of highly pathogenic avian influenza A(H5N8) in Europe – update, 20 November 2014
On 6 November 2014, German authorities reported an outbreak of highly pathogenic avian influenza (HPAI) virus A(H5N8) at a holding with 31 000 fattening turkeys in the north-east of Germany.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV). 19th update, 31 July 2015
This update was prompted in order to reassess the risk for European travellers to South Korea now that there have been no additional cases reported since 4 July 2015.
Severe respiratory disease associated with Middle East respiratory syndrome coronavirus - 21st update, 21 October 2015
This 21st update of ECDC’s risk assessment on MERS-CoV has been triggered by an increase in MERS cases acquired through nosocomial transmission in Amman, Jordan.
Human infection with avian influenza A(H7N9) virus - 5th update, 27 January 2017
Fifth update of the risk assessment on human infection with avian influenza A(H7N9) virus, summarising the epidemiological and virological information on the disease in China and Canada, and assessing the risk to public health in the EU/EEA.